Assessing the safety of drugs for the long-term treatment of peptic ulcers.
作者信息
Wormsley K G
出版信息
Gut. 1984 Dec;25(12):1416-23. doi: 10.1136/gut.25.12.1416.
Abstract
摘要
相似文献
1
Assessing the safety of drugs for the long-term treatment of peptic ulcers.评估用于消化性溃疡长期治疗的药物安全性。
Gut. 1984 Dec;25(12):1416-23. doi: 10.1136/gut.25.12.1416.
2
Future trends in the management of peptic ulcer disease.消化性溃疡疾病管理的未来趋势。
Scand J Gastroenterol Suppl. 1988;146:175-84. doi: 10.3109/00365528809099144.
3
Inhibition of acid and gastric carcinoids.酸与胃类癌的抑制作用。
Gut. 1985 Dec;26(12):1279-83. doi: 10.1136/gut.26.12.1279.
4
[Antagonists of the histamine H2 receptors in the stomach].[胃中组胺H2受体拮抗剂]
Gac Med Mex. 1981 Dec;117(12):472-4.
5
[Gastric acid secretion inhibitors: H2 receptor antagonists (H2RA), proton pump inhibitors (PPI) or acid pump antagonists (APA)].[胃酸分泌抑制剂：H2受体拮抗剂（H2RA）、质子泵抑制剂（PPI）或酸泵拮抗剂（APA）]
Acta Gastroenterol Latinoam. 1996;26(4):263-5.
6
[Pharmacologic treatment of ulcers].[溃疡的药物治疗]
Rev Med Univ Navarra. 1984 Jun;28(2):53-8.
7
Drugs for treatment of peptic ulcers.治疗消化性溃疡的药物。
Med Lett Drugs Ther. 1991 Nov 29;33(858):111-4.
8
Effects of the novel histamine H2-receptor antagonist (+/-)-(E)-1-[2-hydroxy-2-(4-hydroxyphenyl)ethyl]-3-[2-[[[5- (methylamino)methyl-2-furyl]methyl]thio]ethyl]-2-(methylsulfonyl) guanidine on gastric secretion and gastroduodenal ulcers in rats.新型组胺H2受体拮抗剂（±）-（E）-1-[2-羟基-2-（4-羟基苯基）乙基]-3-[2-[[[5-（甲氨基）甲基-2-呋喃基]甲基]硫代]乙基]-2-（甲基磺酰基）胍对大鼠胃分泌和胃十二指肠溃疡的影响
Arzneimittelforschung. 1996 Feb;46(2):177-84.
9
Drugs for treatment of peptic ulcers.治疗消化性溃疡的药物。
J Assoc Acad Minor Phys. 1992;3(3):78-88.
10
Drugs for peptic ulcers.
Treat Guidel Med Lett. 2004 Feb;2(18):9-12.
引用本文的文献
1
Proton pump inhibitors and the risk of gastric cancer: a systematic review, evidence synthesis and life course epidemiology perspective.质子泵抑制剂与胃癌风险：一项系统综述、证据综合及生命历程流行病学视角分析
BMJ Open Gastroenterol. 2025 Apr 19;12(1):e001719. doi: 10.1136/bmjgast-2024-001719.
2
Effect of omeprazole on intragastric bacterial counts, nitrates, nitrites, and N-nitroso compounds.奥美拉唑对胃内细菌计数、硝酸盐、亚硝酸盐及N-亚硝基化合物的影响。
Gut. 1994 Apr;35(4):455-60. doi: 10.1136/gut.35.4.455.
3
Antisecretory drugs and gastric cancer.抗分泌药物与胃癌
Br Med J (Clin Res Ed). 1985 Dec 7;291(6509):1646-7. doi: 10.1136/bmj.291.6509.1646-c.
4
Gastric microflora.胃微生物群
Br Med J (Clin Res Ed). 1985 Aug 10;291(6492):367-8. doi: 10.1136/bmj.291.6492.367.
5
Omeprazole. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peptic ulcer disease and Zollinger-Ellison syndrome.奥美拉唑。对其药效学和药代动力学特性以及在消化性溃疡疾病和佐林格-埃利森综合征中的治疗潜力的初步综述。
Drugs. 1986 Jul;32(1):15-47. doi: 10.2165/00003495-198632010-00002.
6
Peptic ulcer disease. Pathophysiology and current medical management.消化性溃疡病。病理生理学与当前的药物治疗
West J Med. 1987 Jun;146(6):724-33.
7
Misoprostol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of peptic ulcer disease.米索前列醇。对其药效学和药代动力学特性以及治疗消化性溃疡疾病疗效的初步综述。
Drugs. 1987 Jan;33(1):1-30. doi: 10.2165/00003495-198733010-00001.
8
H2-receptor antagonists and gastric cancer.H2受体拮抗剂与胃癌
Med Toxicol. 1986 May-Jun;1(3):163-8. doi: 10.1007/BF03259835.
9
Famotidine. Pharmacodynamic and pharmacokinetic properties and a preliminary review of its therapeutic use in peptic ulcer disease and Zollinger-Ellison syndrome.法莫替丁。药效学和药代动力学特性及其在消化性溃疡疾病和佐林格-埃利森综合征治疗应用的初步综述。
Drugs. 1986 Sep;32(3):197-221. doi: 10.2165/00003495-198632030-00001.
10
Inhibition of human gastric secretion by ICI 162,846--a new histamine H2-receptor antagonist.新型组胺H2受体拮抗剂ICI 162,846对人胃液分泌的抑制作用
Br J Clin Pharmacol. 1986 Jun;21(6):685-9. doi: 10.1111/j.1365-2125.1986.tb05234.x.
本文引用的文献
1
Does cimetidine play a "proinflammatory" role in fundic mucosa of duodenal ulcer patients?
Acta Gastroenterol Belg. 1980 May-Jun;43(5-6):167-72.
2
Cimetidine: further evidence of noncarcinogenicity in dogs.
N Engl J Med. 1981 Mar 12;304(11):672. doi: 10.1056/NEJM198103123041119.
3
Dynamics of chronic gastritis in the remnant after partial gastrectomy for duodenal ulcer.十二指肠溃疡部分胃切除术后残胃慢性胃炎的动态变化
Scand J Gastroenterol. 1980;15(4):509-12. doi: 10.3109/00365528009181509.
4
Precancerous conditions and epithelial dysplasia in the stomach.胃部的癌前病变和上皮发育异常
J Clin Pathol. 1980 Aug;33(8):711-21. doi: 10.1136/jcp.33.8.711.
5
Epithelial proliferation in human fundic mucosa after antrectomy and vagotomy.胃窦切除和迷走神经切断术后人胃底黏膜上皮细胞增殖情况
Gastroenterology. 1980 Nov;79(5 Pt 1):807-11.
6
Alzheimer's disease: X-ray spectrometric evidence of aluminum accumulation in neurofibrillary tangle-bearing neurons.阿尔茨海默病：铝在含有神经原纤维缠结的神经元中蓄积的X射线光谱证据。
Science. 1980 Apr 18;208(4441):297-9. doi: 10.1126/science.7367858.
7
Instrumental neutron activation analysis of brain aluminum in Alzheimer disease and aging.阿尔茨海默病和衰老中脑铝的仪器中子活化分析
Ann Neurol. 1981 Dec;10(6):511-6. doi: 10.1002/ana.410100604.
8
9
Deoxyribonucleic acid methylation in human cells exposed to nitrosocimetidine.暴露于西咪替丁亚硝基化合物的人类细胞中的脱氧核糖核酸甲基化
Biochem Pharmacol. 1981 Oct;30(20):2864-7. doi: 10.1016/0006-2952(81)90427-5.
10
Carcinogen testing: current problems and new approaches.致癌物检测：当前问题与新方法
Science. 1981 Oct 23;214(4519):401-7. doi: 10.1126/science.7291981.
Zotero 插件